![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/4245 | (2006.01) |
A61K 31/4402 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 9/00 | (2006.01) | ||
A61K 9/00 | (2006.01) |
(11) | Number of the document | 4370116 |
(13) | Kind of document | T |
(96) | European patent application number | 22753953.3 |
Date of filing the European patent application | 2022-07-15 | |
(97) | Date of publication of the European application | 2024-05-22 |
(45) | Date of publication and mention of the grant of the patent | 2025-01-15 |
(46) | Date of publication of the claims translation | 2025-04-10 |
(86) | Number | PCT/US2022/073808 |
Date | 2022-07-15 |
(87) | Number | WO 2023/288324 |
Date | 2023-01-19 |
(30) | Number | Date | Country code |
202163203333 P | 2021-07-16 | US | |
202263299753 P | 2022-01-14 | US | |
202263305609 P | 2022-02-01 | US | |
202263331197 P | 2022-04-14 | US | |
202263343975 P | 2022-05-19 | US |
(72) |
MALIK, Fady , US
KUPFER, Stuart , US
HEITNER, Stephen B. , US
ROBERTSON, Laura Ann , US
MENG, Lixin , US
OSMUKHINA, Anna , US
WOHLTMAN, Qi , US
|
(73) |
Cytokinetics, Inc. ,
350 Oyster Point Blvd, South San Francisco CA 94080,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Afikamteno dozavimo režimai, skirti obstrukcinės hipertrofinės kardiomiopatijos gydymui |
AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY |
Payment date | Validity (years) | Amount | |
2025-06-23 | 4 | 92.00 EUR |
2026-07-15 |